Carbogen Amcis, a contract manufacturing offering process development and manufacturing of active pharmaceutical ingredients (APIs), has announced the extension of its operations in Bubendorf, Switzerland.

The company has undersigned the acquisition of the land and buildings of GEA Pharma Systems AG in Bubendorf, close to the company’s current headquarters will become effective on January 1, 2017.

Located on 5,200 square meters of land, the 3,360-square-meter multi-story building is divided into laboratory, production, storage, and office areas and provides a set of cleanroom GMP compliant suites. The company is planning modification work in order to adapt the building to its specific requirements and convert more of the facility into GMP operations areas.

“The immediate proximity to our current headquarters and our larger scale production site in Bubendorf, Switzerland, is ideal. It will allow us to significantly extend our laboratory capacity for highly potent development and small scale production as well as analytical support.” said Stephan Fritschi, vice-president operations at Carbogen Amcis,” in a company release. “Operations are scheduled to expand into the new building in 2017”.

Source: Carbogen Amcis